United States - English - NLM (National Library of Medicine)

pfizer, inc. - dalteparin sodium (unii: 12m44vtj7b) (dalteparin - unii:s79o08v79f) - 2500 [iu] in 0.2 ml

United States - English - NLM (National Library of Medicine)

karalex pharma llc - fenofibrate (unii: u202363uos) (fenofibrate - unii:u202363uos) - fenofibrate 54 mg - fenofibrate tablets are indicated as adjunctive therapy to diet to reduce elevated ldl-c, total-c, triglycerides and apo b, and to increase hdl-c in adult patients with primary hypercholesterolemia or mixed dyslipidemia (fredrickson types iia and iib). lipid-altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and non-pharmacological interventions alone has been inadequate (see national cholesterol education program [ncep] treatment guidelines, below). fenofibrate tablets are also indicated as adjunctive therapy to diet for treatment of adult patients with hypertriglyceridemia (fredrickson types iv and v hyperlipidemia). improving glycemic control in diabetic patients showing fasting chylomicronemia will usually reduce fasting triglycerides and eliminate chylomicronemia thereby obviating the need for pharmacologic intervention. markedly elevated levels of serum triglycerides (e.g. > 2,000 mg/dl) may increase the risk of developing pancreatitis.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride 10 mg

United States - English - NLM (National Library of Medicine)

cardinal health - donepezil hydrochloride (unii: 3o2t2pj89d) (donepezil - unii:8ssc91326p) - donepezil hydrochloride 5 mg

United States - English - NLM (National Library of Medicine)

eisai inc. - decitabine (unii: 776b62cq27) (decitabine - unii:776b62cq27) - decitabine 50 mg in 20 ml

United States - English - NLM (National Library of Medicine)

maternal science, llc - .beta.-carotene (unii: 01yae03m7j) (.beta.-carotene - unii:01yae03m7j), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), cholecalciferol (unii: 1c6v77qf41) (cholecalciferol - unii:1c6v77qf41), .alpha.-tocopherol acetate, dl- (unii: wr1wpi7ew8) (alpha-tocopherol, dl- - unii:7qwa1rio01), thiamine (unii: x66nso3n35) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), pyridoxine hydrochlor - .beta.-carotene 4000 [iu] - prenatal vitamins adults-take one caplet daily with water, preferably with a mean, as a dietary supplement, or as directed by doctor. as with any supplement if you are pregnent, nursing, or taking medication.consult your doctor before use.

United States - English - NLM (National Library of Medicine)

blenheim pharmacal, inc. - cephalexin (unii: obn7uds42y) (cephalexin anhydrous - unii:5sff1w6677) - cephalexin anhydrous 500 mg - cephalexin is indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: respiratory tract infections caused by s. pneumoniae and s. pyogenes (penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present.) otitis media due to s. pneumoniae, h. influenzae, staphylococci, streptococci, and m. catarrhalis skin and skin structure infections caused by staphylococci and/or streptococci bone infections caused by staphylococci and/or p. mirabilis genitourinary tract infections, including acute prostatitis, caused by e. coli, p. mirabilis, and k. pneumoniae note - culture and susceptibility tests should be initiated prior to and during

United States - English - NLM (National Library of Medicine)

lake erie medical & surgical supplies dba quality care products llc - rabeprazole sodium (unii: 3l36p16u4r) (rabeprazole - unii:32828355ll) - rabeprazole sodium 20 mg

United States - English - NLM (National Library of Medicine)

eisai inc. - altretamine (unii: q8bih59o7h) (altretamine - unii:q8bih59o7h) - altretamine 50 mg - hexalen® (altretamine) capsules is indicated for use as a single agent in the palliative treatment of patients with persistent or recurrent ovarian cancer following first-line therapy with a cisplatin and/or alkylating agent-based combination. hexalen® capsules is contraindicated in patients who have shown hypersensitivity to it. hexalen® capsules should not be employed in patients with preexisting severe bone marrow depression or severe neurologic toxicity. hexalen® capsules has been administered safely, however, to patients heavily pretreated with cisplatin and/or alkylating agents, including patients with preexisting cisplatin neuropathies. careful monitoring of neurologic function in these patients is essential.

United States - English - NLM (National Library of Medicine)

carilion materials management - rabeprazole sodium (unii: 3l36p16u4r) (rabeprazole - unii:32828355ll) - rabeprazole sodium 20 mg - aciphex delayed-release tablets are indicated for short-term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (gerd).  for those patients who have not healed after 8 weeks of treatment, an additional 8-week course of aciphex may be considered. aciphex delayed-release tablets are indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease (gerd maintenance).  controlled studies do not extend beyond 12 months. aciphex delayed-release tablets are indicated for the treatment of daytime and nighttime heartburn and other symptoms associated with gerd in adults for up to 4 weeks.  aciphex delayed-release tablets are indicated for short-term (up to four weeks) treatment in the healing and symptomatic relief of duodenal ulcers.  most patients heal within four weeks. aciphex delayed-release tablets, in combination with amoxicillin and clarithromycin as